Success Story: EB1A Approved! Indian Postdoctoral Associate Triumphs Over RFE with Premium Processing
Client’s Testimonial:
“Excellent service. I am very happy with my attorneys. All my questions were answered on time, and my case was prepared and submitted in a timely manner without any delay. Also, I would like to thank all other members of the Chen immigration team who worked hard to prepare my case.”
On May 3rd, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Associate in the Field of Molecular and Cellular Cancer Biology (Approval Notice).
General Field: Molecular And Cellular Cancer Biology
Position at the Time of Case Filing: Postdoctoral Associate
Country of Origin: India
State of Residence at the Time of Filing: California
Approval Notice Date: May 3rd, 2025
Processing Time: 3 months, 27 days (Premium Processing Requested)
Case Summary:
At North America Immigration Law Group, we are pleased to share a recent EB1A (Alien of Extraordinary Ability) success story, demonstrating the strength of our strategic legal approach. We secured EB1A approval for a postdoctoral associate from India, whose case, filed under Premium Processing, was approved in just 3 months and 27 days, despite receiving a Request for Evidence (RFE).
Our client is a molecular and cellular biologist conducting pioneering research on cancer development, drug resistance, genome engineering, and novel therapeutic combinations. He is currently employed as a postdoctoral scientist in the U.S., leading research efforts focused on chromatin remodeling, genomic integrity, and viral mimicry areas with direct applications in cancer treatment.
To support his EB1A petition, we presented a compelling record of achievement:
Publications and Citations: The client has authored 12 peer-reviewed articles and 1 book chapter, with 319 citations and an h-index of 9, placing him in the top 3% of researchers publishing in biological systems. One of his papers ranks among the top 10% most cited in molecular biology and genetics for its publication year.
Peer Review Contributions: He has completed over 80 peer reviews and currently serves on the editorial boards of multiple scientific journals, reinforcing his status as a trusted authority.
Significance and Impact: His discoveries, such as the role of SMURF2 in regulating RNA editing and maintaining chromatin stability, have influenced cancer research worldwide, with citations from researchers across 49 countries.
By demonstrating his extraordinary influence in advancing cancer biology, we successfully secured approval under EB1A. We are proud to support this exceptional scientist as he continues to push the boundaries of cancer research in the United States.

